FDA Inspection 1013090 — Abbott Molecular, Inc.
The FDA completed an inspection of Abbott Molecular, Inc. on May 4, 2017 in Des Plaines, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 4, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Des Plaines, IL (United States)